(Q34989826)
Statements
1 reference
The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo (English)
1 reference
Joel M Kremer
1 reference
Bradley J Bloom
1 reference
Ferdinand C Breedveld
1 reference
John H Coombs
1 reference
Mark P Fletcher
1 reference
David Gruben
1 reference
Sriram Krishnaswami
1 reference
Rubén Burgos-Vargas
1 reference
Bethanie Wilkinson
1 reference
Cristiano A F Zerbini
1 reference
Samuel H Zwillich
1 reference
1 July 2009
1 reference
1 reference
60
1 reference
7
1 reference
1895-1905
1 reference
Identifiers
1 reference
1 reference